These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 20145181)

  • 41. MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.
    Tsukamoto Y; Nakada C; Noguchi T; Tanigawa M; Nguyen LT; Uchida T; Hijiya N; Matsuura K; Fujioka T; Seto M; Moriyama M
    Cancer Res; 2010 Mar; 70(6):2339-49. PubMed ID: 20215506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Amplification and overexpression of PPFIA1, a putative 11q13 invasion suppressor gene, in head and neck squamous cell carcinoma.
    Tan KD; Zhu Y; Tan HK; Rajasegaran V; Aggarwal A; Wu J; Wu HY; Hwang J; Lim DT; Soo KC; Tan P
    Genes Chromosomes Cancer; 2008 Apr; 47(4):353-62. PubMed ID: 18196592
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Alcohol-dysregulated miR-30a and miR-934 in head and neck squamous cell carcinoma.
    Saad MA; Kuo SZ; Rahimy E; Zou AE; Korrapati A; Rahimy M; Kim E; Zheng H; Yu MA; Wang-Rodriguez J; Ongkeko WM
    Mol Cancer; 2015 Oct; 14():181. PubMed ID: 26472042
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The functional significance of microRNA-375 in human squamous cell carcinoma: aberrant expression and effects on cancer pathways.
    Kinoshita T; Hanazawa T; Nohata N; Okamoto Y; Seki N
    J Hum Genet; 2012 Sep; 57(9):556-63. PubMed ID: 22718022
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tumor suppressive microRNA-375 regulates oncogene AEG-1/MTDH in head and neck squamous cell carcinoma (HNSCC).
    Nohata N; Hanazawa T; Kikkawa N; Mutallip M; Sakurai D; Fujimura L; Kawakami K; Chiyomaru T; Yoshino H; Enokida H; Nakagawa M; Okamoto Y; Seki N
    J Hum Genet; 2011 Aug; 56(8):595-601. PubMed ID: 21753766
    [TBL] [Abstract][Full Text] [Related]  

  • 46. microRNA-504 inhibits cancer cell proliferation via targeting CDK6 in hypopharyngeal squamous cell carcinoma.
    Kikkawa N; Kinoshita T; Nohata N; Hanazawa T; Yamamoto N; Fukumoto I; Chiyomaru T; Enokida H; Nakagawa M; Okamoto Y; Seki N
    Int J Oncol; 2014 Jun; 44(6):2085-92. PubMed ID: 24647829
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Changes in circulating microRNAs after radiochemotherapy in head and neck cancer patients.
    Summerer I; Niyazi M; Unger K; Pitea A; Zangen V; Hess J; Atkinson MJ; Belka C; Moertl S; Zitzelsberger H
    Radiat Oncol; 2013 Dec; 8():296. PubMed ID: 24373621
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic impact of disseminated tumor cells and microRNA-17-92 cluster deregulation in gastrointestinal cancer.
    Valladares-Ayerbes M; Blanco M; Haz M; Medina V; Iglesias-Díaz P; Lorenzo-Patiño MJ; Reboredo M; Santamarina I; Figueroa A; Antón-Aparicio LM; Calvo L
    Int J Oncol; 2011 Nov; 39(5):1253-64. PubMed ID: 21743960
    [TBL] [Abstract][Full Text] [Related]  

  • 49. MicroRNA miR-125b induces senescence in human melanoma cells.
    Glud M; Manfé V; Biskup E; Holst L; Dirksen AM; Hastrup N; Nielsen FC; Drzewiecki KT; Gniadecki R
    Melanoma Res; 2011 Jun; 21(3):253-6. PubMed ID: 21460750
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Regulation of Oncogenic Targets by
    Okada R; Koshizuka K; Yamada Y; Moriya S; Kikkawa N; Kinoshita T; Hanazawa T; Seki N
    Cells; 2019 Nov; 8(12):. PubMed ID: 31795200
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Integrated analysis of deregulation microRNA expression in head and neck squamous cell carcinoma.
    Qi CL; Sheng JF; Huang ML; Zou Y; Wang YP; Wang F; Zeng F; Hua QQ; Chen SM
    Medicine (Baltimore); 2021 Feb; 100(6):e24618. PubMed ID: 33578572
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA alterations in head and neck squamous cell carcinoma.
    Chang SS; Jiang WW; Smith I; Poeta LM; Begum S; Glazer C; Shan S; Westra W; Sidransky D; Califano JA
    Int J Cancer; 2008 Dec; 123(12):2791-7. PubMed ID: 18798260
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A microRNA expression ratio defining the invasive phenotype in bladder tumors.
    Neely LA; Rieger-Christ KM; Neto BS; Eroshkin A; Garver J; Patel S; Phung NA; McLaughlin S; Libertino JA; Whitney D; Summerhayes IC
    Urol Oncol; 2010; 28(1):39-48. PubMed ID: 18799331
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Repression of bone morphogenetic protein 4 by let-7i attenuates mesenchymal migration of head and neck cancer cells.
    Yang WH; Lan HY; Tai SK; Yang MH
    Biochem Biophys Res Commun; 2013 Mar; 433(1):24-30. PubMed ID: 23454123
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High-throughput sequencing of small RNA transcriptomes reveals critical biological features targeted by microRNAs in cell models used for squamous cell cancer research.
    Severino P; Oliveira LS; Torres N; Andreghetto FM; Klingbeil Mde F; Moyses R; Wünsch-Filho V; Nunes FD; Mathor MB; Paschoal AR; Durham AM
    BMC Genomics; 2013 Oct; 14():735. PubMed ID: 24160351
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A novel saliva-based microRNA biomarker panel to detect head and neck cancers.
    Salazar C; Nagadia R; Pandit P; Cooper-White J; Banerjee N; Dimitrova N; Coman WB; Punyadeera C
    Cell Oncol (Dordr); 2014 Oct; 37(5):331-8. PubMed ID: 25156495
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miRNA profiling of primary lung and head and neck squamous cell carcinomas: Addressing a diagnostic dilemma.
    Muñoz-Largacha JA; Gower AC; Sridhar P; Deshpande A; O'Hara CJ; Yamada E; Godfrey TE; Fernando HC; Litle VR
    J Thorac Cardiovasc Surg; 2017 Aug; 154(2):714-727. PubMed ID: 28495058
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating microRNAs as prognostic therapy biomarkers in head and neck cancer patients.
    Summerer I; Unger K; Braselmann H; Schuettrumpf L; Maihoefer C; Baumeister P; Kirchner T; Niyazi M; Sage E; Specht HM; Multhoff G; Moertl S; Belka C; Zitzelsberger H
    Br J Cancer; 2015 Jun; 113(1):76-82. PubMed ID: 26057452
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Unpredictable changes of selected miRNA in expression profile of HNSCC.
    Lamperska KM; Kozlowski P; Kolenda T; Teresiak A; Blizniak R; Przybyla W; Masternak MM; Golusinski P; Golusinski W
    Cancer Biomark; 2016; 16(1):55-64. PubMed ID: 26484611
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Loss of miR-125b-1 contributes to head and neck cancer development by dysregulating TACSTD2 and MAPK pathway.
    Nakanishi H; Taccioli C; Palatini J; Fernandez-Cymering C; Cui R; Kim T; Volinia S; Croce CM
    Oncogene; 2014 Feb; 33(6):702-12. PubMed ID: 23416980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.